title: Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.
abstract: Previous studies have reported that mesenchymal stem cells (MSC) may be isolated from the synovial membrane by the same protocol as that used for synovial fibroblast cultivation, suggesting that MSC correspond to a subset of the adherent cell population, as MSC from the stromal compartment of the bone marrow (BM). The aims of the present study were, first, to better characterize the MSC derived from the synovial membrane and, second, to compare systematically, in parallel, the MSC-containing cell populations isolated from BM and those derived from the synovium, using quantitative assays. Fluorescent-activated cell sorting analysis revealed that both populations were negative for CD14, CD34 and CD45 expression and that both displayed equal levels of CD44, CD73, CD90 and CD105, a phenotype currently known to be characteristic of BM-MSC. Comparable with BM-MSC, such MSC-like cells isolated from the synovial membrane were shown for the first time to suppress the T-cell response in a mixed lymphocyte reaction, and to express the enzyme indoleamine 2,3-dioxygenase activity to the same extent as BM-MSC, which is a possible mediator of this suppressive activity. Using quantitative RT-PCR these data show that MSC-like cells from the synovium and BM may be induced to chondrogenic differentiation and, to a lesser extent, to osteogenic differentiation, but the osteogenic capacities of the synovium-derived MSC were significantly reduced based on the expression of the markers tested (collagen type II and aggrecan or alkaline phosphatase and osteocalcin, respectively). Transcription profiles, determined with the Atlas Human Cytokine/Receptor Array, revealed discrimination between the MSC-like cells from the synovial membrane and the BM-MSC by 46 of 268 genes. In particular, activin A was shown to be one major upregulated factor, highly secreted by BM-MSC. Whether this reflects a different cellular phenotype, a different amount of MSC in the synovium-derived population compared with BM-MSC adherent cell populations or the impact of a different microenvironment remains to be determined. In conclusion, although the BM-derived and synovium-derived MSC shared similar phenotypic and functional properties, both their differentiation capacities and transcriptional profiles permit one to discriminate the cell populations according to their tissue origin.
authors.affiliation: INSERM Unit 475, Montpellier, France. djouad@montp.inserm.fr
authors.forename: Farida
authors.initials: F
authors.lastname: Djouad
authors.forename: Claire
authors.initials: C
authors.lastname: Bony
authors.forename: Thomas
authors.initials: T
authors.lastname: Häupl
authors.forename: Gilles
authors.initials: G
authors.lastname: Uzé
authors.forename: Najiba
authors.initials: N
authors.lastname: Lahlou
authors.forename: Pascale
authors.initials: P
authors.lastname: Louis-Plence
authors.forename: Florence
authors.initials: F
authors.lastname: Apparailly
authors.forename: François
authors.initials: F
authors.lastname: Canovas
authors.forename: Thierry
authors.initials: T
authors.lastname: Rème
authors.forename: Jacques
authors.initials: J
authors.lastname: Sany
authors.forename: Christian
authors.initials: C
authors.lastname: Jorgensen
authors.forename: Danièle
authors.initials: D
authors.lastname: Noël
mesh_terms: D028341:Activins / Q000378:metabolism; D053674:Aggrecans; D000469:Alkaline Phosphatase / Q000235:genetics / Q000378:metabolism; D015703:Antigens, CD / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology; D015415:Biomarkers / Q000378:metabolism; D001854:Bone Marrow Cells / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D019070:Cell Lineage; D002478:Cells, Cultured; D024043:Collagen Type II / Q000235:genetics / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D016130:Immunophenotyping / Q000379:methods; D028322:Inhibin-beta Subunits / Q000378:metabolism; D037181:Lectins, C-Type / Q000235:genetics / Q000378:metabolism; D059630:Mesenchymal Stem Cells / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D010003:Osteoarthritis / Q000276:immunology / Q000473:pathology; D015675:Osteocalcin / Q000235:genetics / Q000378:metabolism; D011509:Proteoglycans / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D013583:Synovial Membrane / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D014158:Transcription, Genetic
chemical_list: D053674:Aggrecans; D015703:Antigens, CD; D015415:Biomarkers; D024043:Collagen Type II; D016326:Extracellular Matrix Proteins; D037181:Lectins, C-Type; D011509:Proteoglycans; D012333:RNA, Messenger; C422405:activin A; D028341:Activins; D015675:Osteocalcin; D028322:Inhibin-beta Subunits; D000469:Alkaline Phosphatase